Vanguard Portfolio Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$144M Buy
4,264,743
+354,234
+9% +$14M 0.01% 1335
2026
Q2
$151M Buy
3,910,509
+205,604
+6% +$6.26M 0.01% 1348
2026
Q1
$92M Buy
+3,704,905
New +$95.9M ﹤0.01% 1462

Other funds holding IMVT

Vanguard Portfolio Management's IMVT Position: Q3 2026 in Review

Vanguard Portfolio Management increased its Immunovant (IMVT) stake by 9.1% in Q3 2026, buying an estimated $14M and bringing the position to 4,264,743 shares worth $144M. The position accounts for 0.01% of the portfolio, ranked #1335.

Vanguard Portfolio Management first reported a position in IMVT in Q1 2026 and has held it in 3 quarters since. The position peaked at $151M in Q2 2026. 231 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Vanguard Portfolio Management held 4,264,743 shares of Immunovant worth $144M as of Q3 2026.
  • Vanguard Portfolio Management bought 354,234 Immunovant shares in Q3 2026, an estimated $14M.
  • Immunovant made up 0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1335 holding.
  • Vanguard Portfolio Management first reported a position in Immunovant in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's Immunovant position peaked at $151M in Q2 2026.
  • 231 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.